NEU neuren pharmaceuticals limited

Ann: Comment on research report, page-130

  1. 48 Posts.
    lightbulb Created with Sketch. 9
    Larmarco acts as a crusader against “corrupt” companies which in this instance his “research” appears to be the only “flop”. How on earth Culper Research has any credibility is beyond me. I’d say some restrictions are coming his way for the baseless comments.

    NEU’s answer was a professional reply. I can’t see how they could have done more. Culper Research don’t understand norms in the medical world in regards to retention rates and what makes up statistics. NEU look strong by not engaging directly or saying more IMO. Dust will settle quickly and we will all actually forget about it.

    Onwards and Up!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.598B
Open High Low Value Volume
$12.82 $13.05 $12.53 $6.559M 511.8K

Buyers (Bids)

No. Vol. Price($)
1 1657 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.85 6303 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.